Research Library

Private cord blood banking is more widespread than public banking in Jordan, contributing to misinformation and unequal access to resources. The authors conducted surveys with women in Jordan to examine perspectives toward cord banking in the country in order to inform policymaking, ethics and education about the practice.

This study assesses the attitudes of women in Jordanian maternity clinics with regard to CB banking and transplantation.

While the Food and Drug Administration currently regulates storage and use of cord blood (CB) in the United States, other state and federal guidelines on CB education, awareness and ethical considerations remain variable, and no mandatory international guidelines exist. To help organize and coordinate efforts across the United States and other nations, policymakers should implement regulations for high quality standards for both private and public CB banks.

In addition to their therapeutic potential, cord blood banks raise ethical and regulatory questions, especially in emerging markets in the Arab world. In this article, the authors review cord blood banking in five countries in the region (Jordan, Saudi Arabia, Egypt, Qatar, and the United Arab Emirates) that were selected for their different CB banking policies and initiatives.

Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.

An overview of stem cell research and the policies, particularly in the state of Texas, that regulate these studies.

Kirstin Matthews, fellow in science and technology, answers questions regarding the biology, practical uses and ethical dilemmas surrounding stem cells.

An introduction to stem cells, their potential uses, and domestic and international policies regarding stem cells.